Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Zagazig University
Intralesional methotrexate (MTX) could to be promising conservative alternative for non-melanoma skin cancer (NMSC). Systemic MTX was attempted as adjuvant for locally-advanced NMSC.
Age
20–90
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adult patients of both sexes with histologically-confirmed primary or recurrent non- metastatic NMSCs of different types (BCC,SCC, and/or KA), sites, number, sizes and duration were included in the study.
You may not be if
Hypersensitivity reactions to methotrexate, liver or kidney disease, immunosuppressive conditions, HIV, HBV, and HCV infection, hematological abnormalities and metastasis. Pregnant or lactating women, females in their child-bearing period not using or refusing contraceptive methods, and those who had any other form of NMSC management in the month preceding enrollment.
Clareo Health | Intralesional Versus Intramuscular Methotrexate for Non-melanoma Skin Cancers
